SCHEMBL2492089

SCHEMBL2492089

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1NCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 2/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
ADRB2 P07550 1/20 0.33
FABP4 P15090 1/20 0.33
ADORA1 P30542 2/20 0.33
ADORA2A P29274 1/20 0.33
ESR2 Q92731 1/20 0.33
NLRP3 Q96P20 1/20 0.32
GCGR P47871 1/20 0.32
DHFR P00374 1/20 0.32
HEXA P06865 1/20 0.32
HEXB P07686 1/20 0.32
ALOX5 P09917 1/20 0.32
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
LMNA P02545 2/20 0.31
USP2 O75604 2/20 0.31
CASP1 P29466 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2491950 0.87 LMNA (0.38) MAPTMEN1KMT2ALMNAL3MBTL1
SCHEMBL2492803 0.84 TLR8 (0.41) SMN1; SMN2MAPTMAPK1MEN1KMT2A
SCHEMBL2492227 0.81 TDO2 (0.36) SMN1; SMN2MAPTMAPK1ESR2ALOX5
SCHEMBL2492230 0.75 GCGR (0.38) ADRB2ADORA1ADORA2AGCGRDHFR
SCHEMBL15349383 0.74 FABP4 (0.44) SMN1; SMN2MAPTPKMMAPK1ADRB2
SCHEMBL2491463 0.74 GCGR (0.44) SMN1; SMN2MAPTESR2GCGRDHFR
SCHEMBL28851827 0.72 ALOX5 (0.46) SMN1; SMN2MAPTPKMMAPK1ADRB2
SCHEMBL4870784 0.72 LMNA (0.39) MAPTMAPK1ESR2ALOX5LMNA
SCHEMBL2490178 0.71 BRD4 (0.38) MAPTESR2ALOX5MEN1KMT2A
SCHEMBL2488675 0.70 KDM4E (0.38) SMN1; SMN2MAPTMAPK1GCGRDHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH SMN1; SMN2 3632/4885MAPT 3454/4885PKM 2696/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 SMN1; SMN2 3663/4885MAPT 3294/4885PKM 2451/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R SMN1; SMN2 3592/4885MAPT 3128/4885PKM 2186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.